ertapenem has been researched along with Renal Insufficiency in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, G; Chen, LM; Li, XM | 1 |
| Cheng, KC; Chu, LW; Hon, FK; Mok, MY; Shea, YF | 1 |
| Chou, YC; Lee, KH; Ng, YY; Ueng, YF; Wu, CW; Yang, WC | 1 |
| Cunha, BA; Gerson, S; Giuga, J | 1 |
| Abusada, NJ; Fica, AE | 1 |
| Churchwell, MD; Depestel, DD; Jakob, V; Kinzig, M; Mueller, BA; Patel, JH; Sörgel, F; Stevenson, JM; Vilay, AM | 1 |
| DiNubile, MJ; Majumdar, AK; Nix, DE | 1 |
| Deutsch, PJ; Fisher, A; Hesney, M; Majumdar, AK; Mistry, GC; Sica, D; Swan, S; Wagner, JA; Xi, L; Xu, Y | 1 |
| Burkhardt, O; Derendorf, H; Welte, T | 1 |
2 review(s) available for ertapenem and Renal Insufficiency
| Article | Year |
|---|---|
Pharmacokinetics and pharmacodynamics of ertapenem: an overview for clinicians.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Clinical Trials as Topic; Community-Acquired Infections; Ertapenem; Female; Humans; Lactams; Male; Middle Aged; Renal Insufficiency | 2004 |
Ertapenem: the new carbapenem 5 years after first FDA licensing for clinical practice.
Topics: Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Clinical Trials as Topic; Community-Acquired Infections; Critical Illness; Drug Interactions; Drug Resistance, Bacterial; Endometritis; Ertapenem; Female; Humans; Peritonitis; Protein Binding; Renal Insufficiency; Surgical Wound Infection; Urinary Tract Infections | 2007 |
1 trial(s) available for ertapenem and Renal Insufficiency
| Article | Year |
|---|---|
Pharmacokinetics of ertapenem in patients with varying degrees of renal insufficiency and in patients on hemodialysis.
Topics: Adult; Age Factors; Aged; Aged, 80 and over; Alanine Transaminase; Anti-Bacterial Agents; Area Under Curve; Aspartate Aminotransferases; beta-Lactams; Drug Administration Schedule; Ertapenem; Female; Half-Life; Humans; Infusions, Intravenous; Kidney; Kidney Failure, Chronic; Male; Metabolic Clearance Rate; Middle Aged; Renal Dialysis; Renal Insufficiency; Time Factors | 2006 |
6 other study(ies) available for ertapenem and Renal Insufficiency
| Article | Year |
|---|---|
[The 473rd case: renal failure, abdominal pain, and mental abnormality].
Topics: Abdominal Pain; Adult; Anti-Bacterial Agents; Ertapenem; Gastroenteritis; Humans; Korsakoff Syndrome; Male; Mental Disorders; Peritoneal Dialysis; Peritonitis; Renal Insufficiency; Thiamine; Treatment Outcome; Wernicke Encephalopathy | 2020 |
Delayed recovery from ertapenem induced encephalopathy: case-report and a possible mechanism.
Topics: Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Dose-Response Relationship, Drug; Ertapenem; Female; Humans; Neurotoxicity Syndromes; Renal Insufficiency; Severity of Illness Index; Time Factors | 2013 |
The recommended dose of ertapenem poses a potential risk for central nervous system toxicity in haemodialysis patients - case reports and literature reviews.
Topics: Aged; Anti-Bacterial Agents; Asian People; beta-Lactams; Central Nervous System Diseases; Dose-Response Relationship, Drug; Ertapenem; Female; Humans; Male; Renal Dialysis; Renal Insufficiency | 2015 |
Predictors of ertapenem therapeutic efficacy in the treatment of urinary tract infections (UTIs) in hospitalized adults: the importance of renal insufficiency and urinary pH.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Ertapenem; Female; Hospitalization; Humans; Hydrogen-Ion Concentration; Male; Middle Aged; Renal Insufficiency; Retrospective Studies; Treatment Outcome; Urinary Tract Infections; Urine; Young Adult | 2016 |
Seizures associated with ertapenem use in patients with CNS disorders and renal insufficiency.
Topics: Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; beta-Lactams; Central Nervous System Diseases; Ertapenem; Female; Humans; Male; Middle Aged; Renal Insufficiency; Risk Factors; Seizures | 2008 |
Ertapenem clearance during modeled continuous renal replacement therapy.
Topics: Animals; Anti-Bacterial Agents; beta-Lactams; Dialysis Solutions; Ertapenem; Hemofiltration; Membranes, Artificial; Metabolic Clearance Rate; Models, Biological; Renal Dialysis; Renal Insufficiency; Swine | 2008 |